fda approval of a biosimilar, promising data in myeloma and gbm, and more
Published 4 years ago • 150 plays • Length 9:45Download video MP4
Download video MP3
Similar videos
-
11:50
fda approval in myeloma, priority review in dlbcl, application accepted of a biosimilar, and more
-
10:25
fda approvals in gbm, biosimilar in breast cancer and gastric/gej cancer, and biomarker assay
-
0:52
dr. martin on fda approval of denosumab in multiple myeloma
-
1:17
dr. ferris on fda approval of nivolumab in patients with head and neck cancer
-
7:13
glioblastoma: pathologic features and classification
-
17:25
promising clinical trials for glioblastoma - nicholas butowski, m.d.
-
8:31
fda d.i.s.c.o.: first biosimilar approval for the treatment of cancer
-
30:43
future therapies for glioblastoma multiforme by alfredo quiñones-hinojosa, md | full lecture
-
58:56
newest modalities in treatment of glioblastoma
-
7:01
diagnostic and prognostic markers in glioblastoma
-
26:33
personalized approach to glioblastoma therapy by michael prados, md
-
4:36
inside glioblastoma multiforme: a journey into the deadliest brain tumor
-
5:53
classification and prognosis of glioblastoma
-
4:50
what is glioblastoma?
-
30:10
individual treatments for glioblastoma - charles s. cobbs, md
-
4:08
glioblastoma (year of the zebra)
-
57:43
glioblastoma: an update in treatment and trends
-
1:00
dr. ferris on pembrolizumab and nivolumab in head and neck cancer
-
40:01
overview of brain tumors | 20th annual ucla brain tumor conference